Arpike Private Limited

Arpike Private Limited

Manufactures chemicals, compounds, and pharmaceuticals and provides various agent services.
1953 | Lucknow, Uttar Pradesh (India) | Active

Last Updated:

December 07, 2024
HomeCompanyArpike Private Limited

Who are the key members and board of directors at Arpike?

Executive Team (1)

NameDesignationAppointment DateStatus
Pradeep Khandelwal InManaging Director25-May-1995Current

Board Members(1)

NameDesignationAppointment DateStatus
Nandita Khandelwal In Director 30-Sep-2003Current

Financial Performance of Arpike.

Arpike Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.54% increase. The company also saw a substantial fall in profitability, with a 45.36% decrease in profit. The company's net worth moved up by a moderate rise of 0.33%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
1.54%
Revenue from Operations
1.60%
Total Assets
1.63%
Profit or Loss
-45.36%
Net Worth
0.33%
EBITDA
-289.40%

Charges (Loans)

Open Charges

₹2.70 M

LenderAmountStatus

Union Bank Of India

Creation Date: 01 Jun 2004
₹2.50 MOpen

Union Bank Of India

Creation Date: 28 Jul 2000
₹0.20 MOpen

How Many Employees Work at Arpike?

Arpike has a workforce of 5 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Arpike

Recent activity within the organization

  • Annual General Meeting

    Arpike Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Arpike Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

    31 Mar 2024

  • Charges

    A charge with Union Bank Of India amounted to Rs. 2.50 M with Charge ID 90280581 was registered on 01 Jun 2004.

    01 Jun 2004

  • Director Appointment

    Nandita Khandelwal was appointed as a Director was appointed as a Director on 30 Sep 2003 & has been associated with this company since 21 years 3 months .

    30 Sep 2003

  • Charges

    A charge with Union Bank Of India amounted to Rs. 0.20 M with Charge ID 90279709 was registered on 28 Jul 2000.

    28 Jul 2000

  • Director Appointment

    Pradeep Khandelwal was appointed as a Managing Director was appointed as a Managing Director on 25 May 1995 & has been associated with this company since 29 years 7 months .

    25 May 1995

Frequently asked questions

  • Arpike Private Limited was incorporated on 14 Aug 1953.

  • The authorized share capital of Arpike Private Limited is ₹ 2.40 M and paid-up capital is ₹ 2.40 M.

  • Currently 2 directors are associated with Arpike Private Limited.

    • Pradeep Khandelwal
    • Nandita Khandelwal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Arpike Private Limited is 22 A Psen Road Lucknow India, U P, Uttar Pradesh, 226001.

  • The corporate identification number (CIN) of Arpike Private Limited is U34304UP1953PTC002509 and the company number is 002509 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2022, the revenue trend for Arpike Private Limited has risen by 1.54%.

  • As Per 2022 financial reports, 5 employees are currently employed by Arpike Private Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Arpike Private Limited has experienced an upsurge of 0.33%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Arpike Private Limited amount to ₹ 2.70 M.

  • The most recent Balance Sheet for Arpike Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development